Atheroembolic renal disease: a diagnostic challenge

Atheroembolic renal disease is a part of a multisystem disease and can be defined as renal failure secondary to the occlusion of renal arterioles and glomerular capillaries with cholesterol crystal emboli deriving from the aorta and other major arteries. The kidney is usually involved because of the...

Full description

Saved in:
Bibliographic Details
Published inRecenti progressi in medicina Vol. 99; no. 7-8; p. 377
Main Authors Scolari, Francesco, Turina, Silvia, Venturelli, Chiara, Dallera, Nadia, Valerio, Francesca, Mazzola, Giuseppe, Faberi, Elena, Sottini, Laura, Kenou, Rosyane
Format Journal Article
LanguageItalian
Published Italy 01.07.2008
Subjects
Adrenal Cortex Hormones - therapeutic use
Age Factors
Aged
Atherosclerosis - complications
Clinical Trials as Topic
Diagnosis, Differential
Embolism, Cholesterol - complications
Embolism, Cholesterol - drug therapy
Humans
Hypolipidemic Agents - therapeutic use
Incidence
Kidney Diseases - diagnosis
Kidney Diseases - drug therapy
Kidney Diseases - epidemiology
Kidney Diseases - etiology
Kidney Transplantation
Prognosis
Prospective Studies
Renal Dialysis
Renal Insufficiency - etiology
Renal Insufficiency - therapy
Retrospective Studies
Online AccessGet more information

Cover

More Information
Summary:Atheroembolic renal disease is a part of a multisystem disease and can be defined as renal failure secondary to the occlusion of renal arterioles and glomerular capillaries with cholesterol crystal emboli deriving from the aorta and other major arteries. The kidney is usually involved because of the proximity of the renal arteries to abdominal aorta (where the erosion of atheromatous plaque is most likely to occur), and the high renal blood flow. Cholesterol crystal embolism can also occur in other visceral organs, as well as in the upper and lower extremities. Embolization may occur spontaneously or after angiographic and surgical procedures, and anticoagulation. Atheroembolic renal disease is an important yet underdiagnosed component of the spectrum of kidney diseases associated with atherosclerosis and remains an unexplored field of nephrology research.
ISSN:0034-1193
2038-1840